Weight loss drug Wegovy cut risk of serious heart problems by 20%, study finds

Weight loss drug Wegovy cut risk of serious heart problems by 20%, study finds – CBS News

Watch CBS News

A new study published in the The New England Journal of Medicine by the maker of the popular weight loss drug Wegovy finds the medication could lower the risk of serious and even deadly heart problems by 20%. CBS News chief medical correspondent Dr. Jon LaPook joins “CBS Mornings” to discuss.

Weight loss drug Wegovy cut risk of serious heart problems by 20%, study finds

How to use your Apple Watch to calculate the tip and split a check at a restaurant

Fisker reports wider-than-expected losses, underwhelming deliveries for the third quarter

Fisker reports wider-than-expected losses, underwhelming deliveries for the third quarter

Leave a Reply Cancel reply

Stay Connected test

Georgia realtor receives invitation to play the Masters by mistake | CNN

As Binance works toward redemption, CEO says Trump has been ‘fantastic’ for crypto

Nvidia CEO Jensen Huang says tariff impact won’t be meaningful in the near term

Why startups and tech giants are racing to build a practical quantum computer

Tech layoffs in Southeast Asia mount as unprofitable startups seek to extend their runways

Contact lens maker faces lawsuit after woman said the product resulted in her losing an eye

Why Cristiano Ronaldo’s move to Saudi Arabia means so much for the Gulf monarchy’s sporting ambitions | CNN

Georgia realtor receives invitation to play the Masters by mistake | CNN

Goldman Sachs acquires ETF firm for $2 billion in latest deal to bolster asset management division

Flood warnings issued to residents along Mahaweli River banks extended

Hyundai Motor India shares rise 4% on robust November sales. Check details

Europe’s slow and steady approach to AI could be its edge

Recent News

Goldman Sachs acquires ETF firm for $2 billion in latest deal to bolster asset management division

Flood warnings issued to residents along Mahaweli River banks extended

Hyundai Motor India shares rise 4% on robust November sales. Check details

Europe’s slow and steady approach to AI could be its edge

Browse by Category

Recent News

Goldman Sachs acquires ETF firm for $2 billion in latest deal to bolster asset management division